PlumX Metrics
Embed PlumX Metrics

Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation 1 1See Editorial by van Zonneveld and Rabelink, p. 2037

Kidney International, ISSN: 0085-2538, Vol: 60, Issue: 5, Page: 1716-1725
2001
  • 112
    Citations
  • 0
    Usage
  • 23
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation. Lipid-mediated renal injury is an important component of glomerulosclerosis and its similarity to atherosclerosis is well described. This study focused on the relationship between lipid-mediated injury and inflammation by examining the role of inflammatory cytokines in the regulation of human mesangial cell low-density lipoprotein (LDL) receptors. A human mesangial cell line (HMCL) was used to study the effects of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) on the regulation of LDL receptor mRNA and protein in the presence of a high concentration of native LDL (250 μg/mL). Native LDL caused foam cell formation in HMCL in the presence of antioxidants, TNF-α and IL-1β. Both cytokines overrode LDL receptor suppression induced by a high concentration of LDL and increased LDL uptake by enhancing receptor expression. These cytokines also caused increased expression of SCAP [sterol responsive element binding protein (SREBP) cleavage activation protein], and an increase in the nuclear translocation of SREBP, which induces LDL receptor expression. These observations demonstrate that inflammatory cytokines can modify cholesterol-mediated LDL receptor regulation in mesangial cells, permitting unregulated intracellular accumulation of unmodified LDL and causing foam cell formation. These findings suggest that inflammatory cytokines contribute to lipid-mediated renal damage, and also may have wider implications for the study of inflammation in the atherosclerotic process.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know